Huarong Pharm
Guangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A pharma company developing and manufacturing small molecule drugs.
Small Molecules
Technology Platform
Centered on medicinal chemistry and advanced manufacturing processes for the development and production of small molecule pharmaceuticals.
Opportunities
Potential to capitalize on China's generic drug market expansion and develop novel small molecules for specific therapeutic niches.
Risk Factors
Vulnerable to government-led bulk procurement price cuts and competition from both large domestic pharma and multinational corporations.
Competitive Landscape
Faces intense competition in China's crowded small molecule drug market, competing on cost, quality, and portfolio breadth.